
Citation: AN Mahamad Irfanulla Khan, CS Prashanth, N Srinath. Genetic etiology of cleft lip and cleft palate[J]. AIMS Molecular Science, 2020, 7(4): 328-348. doi: 10.3934/molsci.2020016
[1] | Praveen Kumar Neela, Rajeshwari B.V, Mahamad Irfanulla Khan, Shahistha Parveen Dasnadi, Gosla Srinivas Reddy, Akhter Husain, Vasavi Mohan . Genetic influences on non-syndromic cleft lip palate: The impact of BMP4, RUNX2, PAX7, and TGFB3 allelic variations. AIMS Molecular Science, 2024, 11(4): 322-329. doi: 10.3934/molsci.2024019 |
[2] | Nikhita Bolar, Aline Verstraeten, Lut Van Laer, Bart Loeys . Molecular insights into bicuspid aortic valve development and the associated aortopathy. AIMS Molecular Science, 2017, 4(4): 478-508. doi: 10.3934/molsci.2017.4.478 |
[3] | Irene M. Waita, Atunga Nyachieo, Daniel Chai, Samson Muuo, Naomi Maina, Daniel Kariuki, Cleophas M. Kyama . Genetic polymorphisms in eostrogen and progesterone receptor genes in Papio anubis induced with endometriosis during early stage of the disease. AIMS Molecular Science, 2021, 8(1): 86-97. doi: 10.3934/molsci.2021007 |
[4] | Fumiaki Uchiumi, Akira Sato, Masashi Asai, Sei-ichi Tanuma . An NAD+ dependent/sensitive transcription system: Toward a novel anti-cancer therapy. AIMS Molecular Science, 2020, 7(1): 12-28. doi: 10.3934/molsci.2020002 |
[5] | Rim Khelifi, Afef Jelloul, Houda Ajmi, Wafa Slimani, Sarra Dimassi, Khouloud Rjiba, Manel Dardour, Moez Gribaa, Ali Saad, Soumaya Mougou-Zerelli . Toward autism spectrum disorders and Williams-Beuren syndrome co-occurrence condition in Tunisian patients: Genetic insights. AIMS Molecular Science, 2024, 11(4): 379-394. doi: 10.3934/molsci.2024023 |
[6] | Nesrin R. Mwafi, Dema A. Ali, Raida W. Khalil, Ibrahim N. Alsbou', Ahmad M. Saraireh . Novel R225C variant identified in the HGD gene in Jordanian patients with alkaptonuria. AIMS Molecular Science, 2021, 8(1): 60-75. doi: 10.3934/molsci.2021005 |
[7] | Alicja Florczak, Aleksandra Królikowska, Mateusz Mazurek, Sławomir Woźniak, Zygmunt Domagała . Most relevant genetic factors in ovarian cancer development. AIMS Molecular Science, 2025, 12(1): 1-25. doi: 10.3934/molsci.2025001 |
[8] | Mohammad Shboul, Hela Sassi, Houweyda Jilani, Imen Rejeb, Yasmina Elaribi, Syrine Hizem, Lamia Ben Jemaa, Marwa Hilmi, Susanna Gerit Kircher, Ali Al Kaissi . The phenotypic spectrum in a patient with Glycine to Serine mutation in the COL2A1 gene: overview study. AIMS Molecular Science, 2021, 8(1): 76-85. doi: 10.3934/molsci.2021006 |
[9] | Katarzyna Szewczyk . Typical numerical alterations in genome identified by array CGH analysis in neuroblastoma tumors. AIMS Molecular Science, 2021, 8(4): 248-256. doi: 10.3934/molsci.2021019 |
[10] | Bhuvana Selvaraj, Ganesan Subramanian, Senthil Kumar Ramanathan, Sangeetha Soundararajan, Shettu Narayanasamy . Studies on molecular spectrum of beta thalassemia among residents of Chennai. AIMS Molecular Science, 2022, 9(3): 107-135. doi: 10.3934/molsci.2022007 |
Cleft lip with or without cleft palate (CL/P) is one of the most common congenital birth defects in the craniofacial region [1]. The etiology is polygenic and multifactorial, involving various genetic and environmental factors [2]–[4]. Children born with these defects may suffer from difficulty in speech, hearing, feeding and other psychosocial problems, and their rehabilitation involves a multidisciplinary approach [5]. In 2008, the World Health Organization (WHO) has recognized that birth defects cause significant infant mortality and childhood morbidity and have included CL/P in their global burden of disease (GBD) initiative [6].
The epidemiological data reveal that the prevalence of Cleft lip with or without cleft palate (CL/P) ranges from 1 in 700 to 1000 live births worldwide. It is highest among Asians and American Indians (1:500), average rates in Caucasians (1:1000) and lowest in Africans (1:2500) [7]–[10]. The incidence of cleft lip and palate varies according to geographical location, ethnicity, race, gender and socioeconomic status [11]–[14].
Higher prevalence of clefts has been observed in individuals who live in rural areas and lower socioeconomic status [15]–[17]. The influence of socioeconomic status on the prevalence of orofacial clefts has not been conclusively determined [3],[18]. Possible explanations for this geographic variation and socioeconomic statuses include environmental factors such as nutrition, access to the excellent health care system and lifestyle risk factors such as alcohol, smoking.
Several studies have suggested consanguinity is a risk factor for nonsyndromic cleft lip with or without cleft palate (NSCL/P) [19],[20], whereas systematic reviews and meta-analyses reported that there is almost twice the risk of a child with NSCL/P being born if parental consanguinity exists [21].
The incidence of clefts in India is around 1:800 to 1:1000 and three infants are born with some type of cleft every hour [22]. Indian Council of Medical Research (ICMR) task force project revealed that 15% of CL/P cases had a familial association of cleft whereas, 85% of cases did not reveal any positive familial history [23]. A 13year retrospective study from a cleft center suggested consanguinity is a risk factor for NSCL/P in Indian population [24].
In India, majority of these defects are not surgically corrected because of lack of awareness among parents of child born with a cleft have no access to counseling on the care, affordability and availability of experts to provide the quality treatment. Evidence showed the association of MSX1 [25], IRF6 [26] gene with NSCL/P whereas, CRISPLD2 gene did not show any association with clefts in Indian population [27].
Cleft lip with or without cleft palate (CL/P) can be classified into syndromic and nonsyndromic. Most studies suggest that about 70% of the CL/P cases are nonsyndromic and occur as isolated cases without any other physical abnormalities, whereas 30% of are syndromic which are associated with some other developmental anomalies[28]–[30]. The syndromic cases are significant in number and can be subdivided into chromosomal syndromes, Mendelian disorders, teratogens (e.g. phenytoin or alcohol) and uncategorized syndromes [31],[32].
The frequency of occurrence of cleft lip and cleft palate differs with regard to gender and side of clefting. Cleft lip is more common in males at a 2:1 male to female ratio, whereas a cleft palate is more common in females with a ratio of 1:2 male to female [7],[33]. Approximately 90% of clefts are unilateral [34]. Among unilateral cases of CL/P, left-sided clefts are common (66%) than right-sided clefts at a 2:1 ratio of left- to right-sided clefts [35]. Figure 1 shows the prevalence of cleft lip and cleft palate.
The epidemiological studies have reported, adult patients with CL/P may suffer from various difficulties such as esthetics, difficulty in speech, hearing, and psychosocial problems. These individuals may have episodes of depression, low self-esteem and low emotional development even after achieving satisfactory cosmetic, functional, and speech therapy. Many adults will reach a point at which they refuse take the final stages of dental and other surgical treatment. All these problems associated life-long impact on the quality of life of the CL/P patients [36],[37].
Although the precise etiology of CL/P is unknown, the complex embryogenesis of the lip and palate make these tissues vulnerable to a variety of potential interferences during a critical stage of development. The etiology is believed to be complex and multifactorial, involving various genetic factors, environmental factors and gene-environment interactions.
Evidence for a genetic etiology has been available for many years. Scientific literature shows the heritability of NSCL/P (70%), evidence from twin studies and segregation analysis further confirmed the genetic role in the etiology of CL/P [38],[39]. The risk of CL/P is more when a positive family history exists, and an affected parent has a 3% to 5% risk of having an affected child, when one child is affected, parents have a 40% chance of having another affected child [2].
Several epidemiological studies showed an increased prevalence of CL/P in patients whose mothers were exposed to smoking, alcohol consumption (binge levels), antiepileptic medications, Corticosteroids, nutritional deficiencies (folic acid) and infectious diseases during pregnancy may adversely affect the intrauterine environment during embryogenesis [7],[40]. These environmental factors found to increase the risk of NSCL/P. Recently, maternal illnesses such as hyperthermia, parental occupations, diabetes mellitus and obesity [41] have been identified as risk factors.
The preventive effects of maternal folic acid supplementation on NSCL/P are commonly reported, but the evidence remains generally inconsistent. Van Rooij et al., reported a 74% reduction in CL/P risk with using the folic acid supplements in addition to a high folate diet [42] and Wilcox et al., reported a 39% decrease in CL/P risk with using folic acid but no preventive effects were observed for cleft palate only (CPO) cases [43].
The deficiency of enzymes arylamine N-acetyltransferases (NAT1 and NAT2), glutathione S-transferase (GST), and Cytochrome P450 (CYP1A1) may cause greater risk of CL/P if the individuals were exposed to smoking byproducts during pregnancy. These enzymes play an important role in the detoxification and secretion of smoking byproducts and Cytochrome P450 (CYP1A1) is related to the bioactivation of chemicals such as dioxin in cigarette smoke. The increased risk resulting from exposure to maternal smoking during the periconceptual period raises the possibility that deficiencies in detoxification pathways and genes in certain interactions as a cause of NSCL/P [44].
A study reported that homozygous deletions of S-glutathione transferase M1 (GSTM1) and S-glutathione transferase T1 (GSTT1) in mother genome increased the risk of NSCL/P. However, correlation between smoking status, GSTM1/GSTT1 genotypes and risk of CL/P was not very significant [45]. A population-based case-control and family triad study in Norway showed association between a NAT2 gene and isolated cleft lip in case-triads [40] and, there was no association found between TGFA gene and smoking in the etiology CL/P in Indian population [46].
Maternal alcohol intake (binge levels) in short periods of time will increase risk of CL/P has been supported by association with variation in the alcohol dehydrogenase (ADH1C) gene, because the ADH1C involved in the metabolic pathways of many alcohols. Several studies showed an increased risk of nonsyndromic CL/P in women who reported drinking alcohol during the first trimester, compared with women who did not. The mutation of ADH1C gene has suggested its role in the etiology of NSCL/P [47],[48].
Cleft lip and palate is a complex disorder involving the multiple genes and environmental factors. It is essential to consider gene-environment interaction as it helps for a better understanding of the pathogenesis of the disease and analyzing both susceptible and non-susceptible individuals [49]. Several Studies identified gene-environment interactions of maternal smoking, maternal alcohol consumption and folic acid deficiency as a causative factor for NSCL/P [50],[51].
Maternal smoking and folic acid intake are the two important factors that appear to modify genetic risks for cleft lip and palate. Studies have found gene-environment interactions between smoking and variants in transforming growth factors (TGF), muscle segment homeobox (MSX) and retinoic acid receptor genes [52]. Two polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene C677T and A1298C have been shown to decrease MTHFR activity and the C677T polymorphism also decreases circulating folate and increases homocysteine levels and associated with an increased risk of NSCL/P in Asian populations. [53]. The observation that drinking high doses of alcohol in short periods of time will increase risk of CL/P has been supported by association with variation in the alcohol dehydrogenase (ADH1C) gene [47]. Genetic variants in TGFA, TGFB3 and MSX1 genes have been investigated for interactions with environmental risk factors such as smoking, alcohol consumption [54].
A variety of genetic approaches have been used to identify genes and loci contributing to CL/P which includes animal models expression studies, genomic rearrangements and copy number variants, linkage studies, candidate gene-based association studies, candidate gene sequencing and genome-wide association (GWA) studies [4],[55].
In the recent genomic era, advances in genetics and molecular biology techniques have explored the genetic basis of development of these craniofacial defects, and several genes and loci associated with CL/P have been discovered. This article provides an overview of the genes implicated in the etiology of Nonsyndromic CL/P (NSCL/P) as suggested by different human genetic studies, animal models, and other expression studies. Table 1 demonstrates the list of genes involved in the etiology of Nonsyndromic CL/P.
Gene | Chromosomal location | OMIM | Evidence | References |
IRF6 | 1q32.2 | 607199 | GWAS, LD, L, M | [57],[60],[62],[64] |
MSX1 | 4p16.2 | 142983 | LD, M, GWAS | [65],[67],[69]–[71] |
TGFA | 2p13.3 | 190170 | LD, GWAS | [73],[75],[76],[78] |
BMP4 | 14q22.2 | 112262 | M | [79],[81],[83] |
PAX7 | 1p36.13 | 167410 | GWAS | [85],[87],[89],[90] |
RUNX2 | 6p21.1 | 600211 | GWAS | [91],[93],[95] |
SUMO1 | 2q33.1 | 601912 | M | [96],[98],[99] |
VAX1 | 10q25.3 | 604294 | GWAS, LD | [100],[102],[104] |
FOXE1 | 9q22.33 | 602617 | L, LD, M | [108],[109] |
CRISPLD2 | 16q24.1 | 612434 | LD, GWAS | [110],[112],[113] |
MTHFR | 1p36.22 | 607093 | LD, GWAS | [116],[118] |
WNT9B | 17q21.32 | 602864 | M, LD | [122],[124],[127] |
MYH9 | 22q12.3 | 160775 | LD | [134],[136],[138] |
TGFB3 | 14q24.3 | 190230 | M, LD,GWAS | [145],[146] |
SPRY2 | 13q31.1 | 602466 | M | [147],[157] |
PDGFC | 4q32.1 | 608452 | LD, M | [148],[149] |
FGFR2 | 10q26.13 | 176943 | M | [150] |
NOG | 17q22 | 602991 | GWAS, LD | [151],[152] |
ARHGAP29 | 1p22.1 | 610496 | M, GWAS | [153],[154],[157] |
CDH1 | 16q22.1 | 192090 | M | [155],[156] |
THADA | 2p21 | 611800 | GWAS | [157],[158] |
GSTM1 | 1p13.3 | 138350 | M | [45] |
JAG2 | 14q32.33 | 602570 | M, LD | [147],[159] |
KIF7 | 15q26.1 | 611254 | M | [139],[160] |
NAT2 | 8p22 | 612182 | LD | [161],[162] |
PAX3 | 2q36.1 | 606597 | GWAS | [163] |
PHF8 | Xp11.22 | 300560 | M | [164],[165] |
RARA | 17q21.2 | 180240 | L | [166] |
MMP3 | 11q22.2 | 185250 | M | [167],[168] |
TIMP2 | 17q25.3 | 188825 | M, LD | [169],[170] |
Notes: *GWAS: Genome-wide association studies, L: Linkage, M: Mutations, LD: Linkage disequilibrium.
The Interferon regulatory factor-6 (IRF6) is one of the most important and consistent gene implicated in the etiology of CLP and belongs to a family of transcription factors that share a highly conserved helix-turn-helix DNA-binding domain. It is located on the ‘q’ arm of chromosome 1, between positions 32.3 and 41. Van der Woude's syndrome (VDWS) is the most common form of syndromic CL/P and is characterized by CL/P, isolated CP, pits or mucous cysts on the lower lip, and hypodontia and accounts for 2% of all CL/P cases [56]. Popliteal pterygium syndrome (PPS) has all the features of VDWS plus popliteal pterygium, toe/fingers abnormality, syndactyly, and genital abnormalities. Mutation in the IRF6 causes these two autosomal dominant syndromes in CL/P [57], thereby confirming a common genetic etiology in both syndromes.
Evidence of IRF6 causing CLP/CP, has been confirmed in several populations by the research of Zucchero et al. (2004), Blanton et al. (2005), Jugessur et al. (2008), Huang et al. (2009) and subsequently in GWAS meta-analysis [58]–[62]. AGenome-wide association (GWA) study consisting of NSCL/P case-parent trios from different populations showed four SNPs of IRF6 having strong genome-wide significance with orofacialclefting [63]. Other studies also reported the substantial contribution of IRF6 in the etiology of nonsyndromic CL/P [25],[64].
Muscle segment homeobox 1 (MSX1) regulates and stimulates the appropriate protein required dedifferentiation process. It is also known as homeobox protein MSX-1/HOX7/MSH Homeo Box Homolog 1 (Drosophila) gene.HumanMSX1 gene located at 4p16.1 spans around 4.05 kb and consists of two exons and one intron. MSX1 gene has a role in cyclin D1 up-regulation; thus, it inhibits cell differentiation. It plays a vital role during the development of teeth and craniofacial structures.
In homozygous transgenic mice models, nonfunctioning Msx1 gene showed cleft palate and facial and dental abnormalities [65]. In humans, a nonsense mutation of MSX1 resulted in autosomal dominant tooth agenesis, cleft lip and cleft palate, isolated cleft palate in a Dutch family, suggesting MSX1 involvement in human clefting [66],[67]. Several studies in different populations and a meta-analysis have reported the MSX1 gene as a causative factor in NSCL/P [68]–[71].
Transforming Growth Factor Alpha gene encodes a growth factor that binds the epidermal growth factor receptor, which activates a signaling pathway for cell proliferation, differentiation and development, so this gene has been studied extensively in the family of growth factors. TGFA plays an important role in the development of palate and present in the medial edge epithelium of palatal shelves. Several studies have demonstrated a significant association between transforming growth factor-alpha (TGFA) and CL/P [72]. A study showed infants with TGFA genotype whose mothers did not use multivitamins containing folic acid periconceptionally are at a higher risk of being born with CL/P [73]. A meta-analysis and other studies showed inconclusive data and failure of association between TGFA with CL/P due to genetic heterogeneity [74],[75]. A combined case-parent trios and case-control study suggested gene to gene interaction between TGFA and IRF6 influences the risk of developing cleft lip with/without cleft palate [76]. Recently, two meta-analyses confirmed the TGFA Taq 1 polymorphism may be associated with the risk of CL/P [77],[78].
BMP4 is a member of the BMP family and transforming growth factor beta (TGFB) superfamily of secretory signaling molecules that play crucial roles during cartilage and bone formation, tooth development and facial development. It is located on chromosome 14q22.2, consists of 5 exons and spans about 7 kb. Mutations in this gene are associated with orofacial cleft and microphthalmia in humans. A study reported BMP4 mutation in a child caused cleft lip and palate [79]. Several studies have suggested the risk of nonsyndromic oral clefts may be influenced by variation in the BMP4 gene [80],[81]. Two different meta-analyses also confirmed the association of BMP4 gene SNP (rs17563) with NSCL/P [82],[83].
Paired box 7 genesis a member of the paired box (PAX) family, encode for specific DNA binding transcription factors and located at 1p36.13. It contains a paired box domain, an octapeptide, and a paired-type homeodomain. The Functions of PAX7 includes Neural crest development, fetal development, expressed in palatal shelves of the maxilla, Meckel's cartilage, Nasal cavity and Myogenesis. Animal studies showed that mutant mice have a malformation of the maxilla and thus confirming its role in craniofacial development [84].
In humans, a case-parent trio study of PAX7 associated with NSCL/P in four populations (76 from Maryland, 146 from Taiwan, 35 from Singapore, and 40 from Korea) where they assessed the maternal transmission effects of PAX7 genes and they concluded that these genes might influence the risk of CL/P [85], a meta-analysis [86], genome-wide association studies [87],[88] and other studies suggested a role of PAX7 in the etiology of NSCL/P [89],[90].
RUNX2 is a member of the RUNX family of transcription factors and encodes a nuclear protein with a Runt DNA-binding domain which is essential for osteoblastic differentiation and skeletal morphogenesis. In humans and mice study showed, the RUNX2 act as a transcriptional regulator for bone formation and tooth development. Mutations in the RUNX2 gene cause a rare autosomal dominant disorder cleidocranial dysplasia, characterized by skeletal defects, supernumerary teeth, and delayed tooth eruption, clefts of the palate or submucous palate [91]–[93]. A case-parent trio design consists of four populations (Maryland, Taiwan, Singapore, and Korea) were genotyped for 24 single nucleotide polymorphisms (SNPs) of RUNX2 gene, among that three SNPs showed significant excess maternal transmission suggesting RUNX2 may influence the risk of NSCL/P through imprinting effects [94]. Evidence of gene-environment interaction of the RUNX2 gene in a Chinese case-parent trio design showed maternal over-transmission RUNX2 markers and suggested it may influence the susceptibility to NSCL/P through interacting with environmental tobacco smoke [95].
SUMO1 is a protein coding gene involved in various cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. In Mouse model, haploinsufficiency of Sumo1 gene resulted in cleft palate [96]. In humans, genetic associations between NSCL/P and SUMO1 variants have been reported in different populations [97],[98]. A meta-analysis provided empirical evidence of 4 single-nucleotide polymorphisms (SNPs) in the SUMO1 gene contribute to the risk of nonsyndromic cleft lip with or without palate [99].
Ventral anterior homeobox1 is a transcriptional regulator containing a DNA binding homeobox domain. Genes of this family are involved in the regulation of body development and morphogenesis. The homeobox sequences of mouse and human VAX1 are identical. It is expressed in various craniofacial structures, and its deficiency causes cleft palate [100]. A homozygous missense mutation of vax1 was expressed in an Egyptian child from a consanguineous family with bilateral microphthalmia, bilateral CLP, and corpus callosum agenesis [101]. GWAS using case-parent triads from different populations two rare missense mutations in VAX1replicated previous GWAS findings for markers in VAX1 in the Asian and Saudi population, and identified rare variants of VAX1 that may contribute to the etiology of CL(P) [102]–[104].
The FOXE1 belongs to a forkhead box (FOX)/winged helix-domain transcription factor family involved in embryogenesis and located at 9q22.33. A mouse model study showed thyroid agenesis, cleft palate [105] similar to previously reported [106]. Mutations within the FOXE1 gene in two siblings resulted in congenital hypothyroidism, athyroidal and Cleft Palate [107]. Genome-wide association studies (GWAS) and meta-analyses also reported the significant association between FOXE1 and nonsyndromic CL/P in different populations [108],[109].
CRISPLD2 gene located on chromosome 16q24.1 contains 15 exons and extends about 110 kb. In mouse embryos, Crispld2 expressed in nasopharynx, mandible, nasal cartilage, palate, and tooth development [110],[111]. Three SNPs of CRISPLD2 in a northern Chinese population [112],[113] and Next-generation sequencing of eighteen SNPs of CRISPLD2 confirmed genetic polymorphism with an increased risk of NSCL/P in a Chinese Xinjiang Uyghur population [114], in contrast, three SNPs rs1546124, rs4783099, and rs16974880 of CRISPLD2 gene did not show any association with clefts in Indian population [27].
Methylenetetrahydrofolate reductase (MTHFR) located on 1q36 and is a major enzyme of folic acid metabolism. Mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency [115]. Several associations have been reported between the polymorphisms of the MTHFR gene and the risk of NSCL/P [116]–[118]. A systematic review and meta-analysis reported the association of MTHFR polymorphism of SNP (rs1801133) as a risk factor for NSCL/P [119]. A Next-generation sequencing study identified the mutation (c.G586A, p.G196S) in the MTHFR gene as a possible cause of NSCL/P [120].
WNT9B is a member of the WNT gene family that encodes extracellular signaling proteins. These genes are required for body axis patterning, cell fate specification, cell proliferation and cell migration during embryonic development. WNT9B directly regulates facial development and expressed in the facial ectoderm at critical stages of midfacial morphogenesis [121]. WNT9B mRNA is expressed in maxillary, medial nasal, and lateral nasal ectoderm. During lip fusion, WNT9B is expressed in the epithelial seam between the fusing medial and lateral nasal processes [122],[123]. It also signal through the canonical Wnt signaling pathway to regulate midfacial development and lip fusion and are therefore candidategene for an etiological role in NSCL/P [124],[125].
Several studies have reported the involvement of WNT9B gene in the families of NSCL/P [126]–[129]. A miRNA study confirmed the role of miR-497-5p and miR-655-3p in the etiology of CL/P by inhibiting cell proliferation during lip fusion [130].
Myosin heavy chain 9 (MYH9) is located on chromosome 22q13.1 and encodes myosin IIA heavy chain, which participates in a number of cellular functional activities, including the maintenance of cell shape, cytokinesis, migration, and adhesion [131]. It has been reported that polymorphisms of MYH9 are associated with a variety of diseases, including MYH9–related diseases (MYH9-RD), macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss and deafness, and cleft lip and palate [132]. During palatal morphogenesis, MYH9 is abundantly expressed in midline epithelial seam (MES) of palatal shelves before fusion suggesting its role during palate development and contribute to NSCL/P [133].
Several studies have reported the MYH9 role in the etiology of NSCL/P [134]–[136]. Further, a next-generation sequencing study consisted of 103 cases of nonsyndromicorofacial clefts and 100 normal controls in the Taiwanese population [137] and a case-control study also confirmed MYH9 association with NSCL/P [138].
A variety of genetic approaches have identified several genes and loci contributing to etiology of NSCL/P. Candidate genes located on different chromosomes involved in the etiology of NSCL/P is shown in Figure 2.
Advances in molecular and cellular biology techniques have led the way to the discovery of multiple genes involved in the etiology of NSCL/P. A multicenter association study identified various genes significantly associated with NSCL/P, including MSX1, SPRY1, MSX2, PRSS35, TFAP2A, SHH, VAX1, TBX10, WNT11, PAX9, BMP4, JAG2, AXIN2, DVL2, KIF7, and TCBE3, a Stepwise regression analysis revealed that out of 16 genes, 11 genes contributed to 15.5% of the etiology of NSCL/P in a Brazilian population [139]. Different genome-wide association studies have reported multiple candidate genes such as IRF6, MSX1, SPRY1, SPRY2, CHD7, GABRB3, NOG, NTN1, MMP16, KRT18, DICER1, RAD54B, CREBBP, GADD45G, TFAP2A, VAX1, GSC, PTCH1, MYC, TAF1B, MAFB, OFCC1, ARHGAP29, WNT9B, FGFR1, FGF10 [140],[141] although 26 genes were studied, only 14 genes were associated with clefts in Chinese population. A Microarray hybridization analysis reportedCOL11A1, TERT, MIR4457, CLPTM1,ESR1, GLI3, OFD1, TBX1, PHF8 and FLNA, POMGNT2, WHSC1, GRM5, ALX1, DOCK9, PAX9, DLK1, FOXC2-FOXL1, MAU2, IRF6, MYCN,VAX1, MAFB [142] association in the etiology of NSCL/P in Chinese population, among these genes, only 14 genes were identified in the pathogenesis of NSCL/P and this evidence suggest that, genetic heterogeneity between the sub-phenotypes of NSCL/P and among different populations.
The etiology of cleft lip and palate is polygenic and multifactorial, model of inheritance can be influenced by several factors, such as gender of the affected individual, severity of the orofacial cleft, and number of affected relatives. Results from previous studies support the presence of heterogeneity among populations and the presence of multiple genes involved in the etiology of CL/P. Due to genetic heterogeneity associated with NSCL/P, a family with several affected individuals can actually represent the segregation of a single-gene disorder, which would not be promptly recognized based solely on clinical evaluation. The recurrence risk among families with one first-degree affected relative may vary depending on the population and the identification of other individuals with CL/P in the family should be always interpreted with caution [143],[144].
Significant knowledge of the genetic etiology and risk factors of CL/P has already been gained and is being used to reduce the overall health burden of these defects. Identification of specific genetic and environmental causes of CL/P could enable major changes in genetic counseling, improved programs for personalized medicine applications and aid in taking effective preventive measures. With the advances in genomic technology, understanding of the genetic mechanisms leading to CL/P will be achieved in the upcoming years and this will allow more accurate methods of genetic screening, identification high risk individuals and families, and improved prenatal diagnosis.
Genetic studies in humans have demonstrated that Cleft lip with or without cleft palate (CL/P) have a diverse genetic background and probably environmental factors influencing these malformations. Several studies have suggested genetic factors play an important role in the etiology of CL/P and by understanding the relative contribution of these candidate genes could be integrated into a genetic test for the weighed risk of CL/P.
Web Resources:
[1] |
Schutte BC, Murray JC (1999) The many faces and factors of orofacial clefts. Hum Mol Genet 8: 1853-1859. doi: 10.1093/hmg/8.10.1853
![]() |
[2] |
Bender PL (2000) Genetics of cleft lip and palate. J Pediatr Nurs 15: 242-249. doi: 10.1053/jpdn.2000.8148
![]() |
[3] |
Spritz RA (2001) The genetics and epigenetics of Orofacial clefts. Curr Opin Pediatr 13: 556-560. doi: 10.1097/00008480-200112000-00011
![]() |
[4] |
Leslie EJ, Marazita ML (2013) Genetics of Cleft Lip and Cleft Palate. Am J Med Genet C Semin Med Genet 163: 246-258. doi: 10.1002/ajmg.c.31381
![]() |
[5] |
Stanier P, Moore GE (2004) Genetics of cleft lip and palate: syndromic genes contribute to the incidence of non-syndromic clefts. Hum Mol Genet 13: R73-81. doi: 10.1093/hmg/ddh052
![]() |
[6] |
Mossey P, Little J (2009) Addressing the challenges of cleft lip and palate research in India. Ind J Plast Surg (supplement 1) 42: S9-S18. doi: 10.4103/0970-0358.57182
![]() |
[7] |
Dixon MJ, Marazita ML, Beaty TH, et al. (2011) Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet 12: 167-178. doi: 10.1038/nrg2933
![]() |
[8] |
Mossey PA, Little J, Munger RG, et al. (2009) Cleft lip and palate. Lancet 374: 1773-1785. doi: 10.1016/S0140-6736(09)60695-4
![]() |
[9] |
Croen LA, Shaw GM, Wasserman CR, et al. (1998) Racial and ethnic variations in the prevalence of orofacial clefts in California, 1983–1992. Am J Med Genet 79: 42-47. doi: 10.1002/(SICI)1096-8628(19980827)79:1<42::AID-AJMG11>3.0.CO;2-M
![]() |
[10] | Ching GHS, Chung CS (1974) A genetic study of cleft lip and palate in Hawaii. 1. Interracial crosses. Am J Hum Genet 26: 162-172. |
[11] | Murray JC, Daack-Hirsch S, Buetow KH, et al. (1997) Clinical and epidemiologic studies of cleft lip and palate in the Philippines. Cleft Palate Craniofac J 34: 7-10. |
[12] | Vanderas AP (1987) Incidence of cleft lip, cleft palate, and cleft lip and palate among races: a review. Cleft Palate J 24: 216-225. |
[13] |
Hagberg C, Larson O, Milerad J (1997) Incidence of cleft lip and palate and risks of additional malformations. Cleft Palate Craniofac J 35: 40-45. doi: 10.1597/1545-1569_1998_035_0040_ioclap_2.3.co_2
![]() |
[14] | Ogle OE (1993) Incidence of cleft lip and palate in a newborn Zairian sample. Cleft Palate Craniofac J 30: 250-251. |
[15] |
Chung CS, Mi MP, Beechert AM, et al. (1987) Genetic epidemiology of cleft lip with or without cleft palate in the population of Hawaii. Genetic Epidemiol 4: 415-423. doi: 10.1002/gepi.1370040603
![]() |
[16] |
Wyszynski DF, Wu T (2002) Prenatal and perinatal factors associated with isolated oral clefting. Cleft Palate Craniofac J 39: 370-375. doi: 10.1597/1545-1569_2002_039_0370_papfaw_2.0.co_2
![]() |
[17] |
Mossey PA (2007) Epidemiology underpinning research in the etiology of orofacial clefts. Orthod Craniofac Res 10: 114-120. doi: 10.1111/j.1601-6343.2007.00398.x
![]() |
[18] |
Yang J, Carmichael SL, Canfield M, et al. (2008) Socioeconomic status in relation to selected birth defects in a large multicentered US case-control study. Am J Epidemiol 167: 145-154. doi: 10.1093/aje/kwm283
![]() |
[19] |
Sabbagh HJ, Innes NP, Sallout BI, et al. (2015) Birth prevalence of non-syndromicorofacial clefts in Saudi Arabia and the effects of parental consanguinity. Saudi Med J 36: 1076-1083. doi: 10.15537/smj.2015.9.11823
![]() |
[20] |
Silva CM, Pereira MCM, Queiroz TB, et al. (2019) Can Parental Consanguinity Be a Risk Factor for the Occurrence of Nonsyndromic Oral Cleft? Early Hum Dev 135: 23-26. doi: 10.1016/j.earlhumdev.2019.06.005
![]() |
[21] |
Sabbagh HJ, Hassan MH, Innes NP, et al. (2014) Parental Consanguinity and Nonsyndromic Orofacial Clefts in Children: A Systematic Review and Meta-Analyses. Cleft Palate Craniofac J 51: 501-513. doi: 10.1597/12-209
![]() |
[22] |
Reddy SG, Reddy RR, Bronkhorst EM, et al. (2010) Incidence of cleft lip and palate in the state of Andhra Pradesh, South India. Indian J Plast Surg 43: 184-189. doi: 10.4103/0970-0358.73443
![]() |
[23] | Indian Council of Medical Research (ICMR) Task Force Project (2016) Division of Non-Communicable Diseases; New Delhi. |
[24] |
Neela PK, Reddy SG, Husain A, et al. (2019) Association of cleft lip and/or palate in people born to consanguineous parents: A 13year retrospective study from a very high volume cleft center. J Cleft Lip Palate Craniofac Anoma l6: 33-37. doi: 10.4103/jclpca.jclpca_34_18
![]() |
[25] |
Babu GV, Syed AH, Murthy J, et al. (2018) IRF6 rs2235375 single nucleotide polymorphism is associated with isolated non-syndromic cleft palate but not with cleft lip with or without palate in South Indian population. Braz J Otorhinolaryngol 84: 473-477. doi: 10.1016/j.bjorl.2017.05.011
![]() |
[26] |
Babu GV, Syed AH, Murthy J, et al. (2015) Evidence of the involvement of the polymorphisms near MSX1 gene in non-syndromic cleft lip with or without cleft palate. Int J Pediatr Otorhinolaryngol 79: 1081-1084. doi: 10.1016/j.ijporl.2015.04.034
![]() |
[27] |
Neela PK, Reddy SG, Husain A, et al. (2020) CRISPLD2 Gene Polymorphisms with Nonsyndromic Cleft Lip and Palate in Indian Population. Global Med Genet 7: 22-25. doi: 10.1055/s-0040-1713166
![]() |
[28] |
Tolarova MM, Cervenka J (1998) Classification and birth prevalence of Orofacial clefts. Am J Med Genet 75: 126-137. doi: 10.1002/(SICI)1096-8628(19980113)75:2<126::AID-AJMG2>3.0.CO;2-R
![]() |
[29] | Wong FK, Hagg U (2004) An update on the aetiology of orofacial clefts. Hong Kong Med J 10: 331-336. |
[30] |
Rahimov F, Jugessur A, Murray JC (2012) Genetics of Nonsyndromic Orofacial Clefts. Cleft Palate Craniofac J 49: 73-91. doi: 10.1597/10-178
![]() |
[31] | Jones MC (1988) Etiology of facial clefts. Prospective evaluation of 428 patients. Cleft Palate J 25: 16-20. |
[32] | Kohli SS, Kohli VS (2012) A comprehensive review of the genetic basis of cleft lip and palate. J Oral MaxillofacPathol 16: 64-72. |
[33] |
Wyszynski DF, Wu T (2002) Prenatal and perinatal factors associated with isolated oral clefting. Cleft Palate Craniofac J 39: 370-375. doi: 10.1597/1545-1569_2002_039_0370_papfaw_2.0.co_2
![]() |
[34] | Cobourne MT (2012) Cleft Lip and Palate. Epidemiology, Aetiology and Treatment. Front Oral Biol London: Karger, 60-70. |
[35] | Gundlach KK, Maus C (2006) Epidemiological studies on the frequency of clefts in Europe and world-wide. J Craniomaxillofac Surg 34: 1-2. |
[36] | Hobbs J (1991) The adult patient. Clin Commun Disord 1: 48-52. |
[37] |
Murthy J (2009) Management of cleft lip and palate in adults. Indian J Plast Surg 42: S116-S122. doi: 10.4103/0970-0358.57202
![]() |
[38] |
Murray JC (2002) Gene/environment causes of cleft lip and/or palate. Clin Genet 61: 248-256. doi: 10.1034/j.1399-0004.2002.610402.x
![]() |
[39] |
Funato N, Nakamura M (2017) Identification of shared and unique gene families associated with oral clefts. Int J Oral Sci 9: 104-109. doi: 10.1038/ijos.2016.56
![]() |
[40] |
Lie RT, Wilcox AJ, Taylor J, et al. (2008) Maternal smoking and oral clefts: the role of detoxification pathway genes. Epidemiology 19: 606-615. doi: 10.1097/EDE.0b013e3181690731
![]() |
[41] |
Stothard KJ, Tennant PW, Bell R, et al. (2009) Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 301: 636-650. doi: 10.1001/jama.2009.113
![]() |
[42] |
Van Rooij IA, Ocké MC, Straatman H, et al. (2004) Periconceptional folate intake by supplement and food reduces the risk of nonsyndromic cleft lip with or without cleft palate. Prev Med 39: 689-694. doi: 10.1016/j.ypmed.2004.02.036
![]() |
[43] |
Wilcox AJ, Lie RT, Solvoll K, et al. (2007) Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ 334: 464. doi: 10.1136/bmj.39079.618287.0B
![]() |
[44] |
Martyn TC (2004) The complex genetics of cleft lip and palate. Eur J Orthod 26: 7-16. doi: 10.1093/ejo/26.1.7
![]() |
[45] | Hozyasz KK, Mostowska A, Surowiec Z, et al. (2005) Genetic polymorphisms of GSTM1 and GSTT1 in mothers of children with isolated cleft lip with or without cleft palate. Przegl Lek 62: 1019-1022. |
[46] |
Junaid M, Narayanan MBA, Jayanthi D, et al. (2018) Association between maternal exposure to tobacco, presence of TGFA gene, and the occurrence of oral clefts. A case control study. Clin Oral Investig 22: 217-223. doi: 10.1007/s00784-017-2102-6
![]() |
[47] |
Chevrier C, Perret C, Bahuau M, et al. (2005) Interaction between the ADH1C polymorphism and maternal alcohol intake in the risk of nonsyndromic oral clefts: an evaluation of the contribution of child and maternal genotypes. Birth Defects Res A Clin Mol Teratol 73: 114-122. doi: 10.1002/bdra.20103
![]() |
[48] |
Jugessur A, Shi M, Gjessing HK, et al. (2009) Genetic determinants of facial clefting: analysis of 357 candidate genes using two national cleft studies from Scandinavia. PLoS One 4: e5385. doi: 10.1371/journal.pone.0005385
![]() |
[49] | Mossey PA, Little J (2002) Epidemiology of oral clefts: An international perspective. Cleft lip and palate: From origin to treatment Oxford: Oxford University Press, 127-144. |
[50] |
Krapels IP, van Rooij IA, Ocke MC, et al. (2004) Maternal nutritional status and the risk for orofacial cleft offspring in humans. J Nutr 134: 3106-3113. doi: 10.1093/jn/134.11.3106
![]() |
[51] |
Hayes C, Werler MM, Willett WC, et al. (1996) Case-control study of periconceptional folic acid supplementation and orofacial clefts. Am J Epidemiol 143: 1229-1234. doi: 10.1093/oxfordjournals.aje.a008710
![]() |
[52] |
Thomas D (2010) Gene-environment-wide association studies: emerging approaches. Nat Rev Genet 11: 259-272. doi: 10.1038/nrg2764
![]() |
[53] |
Zhao M, Ren Y, Shen L, et al. (2014) Association between MTHFR C677T and A1298C Polymorphisms and NSCL/P Risk in Asians: A Meta-Analysis. PLoS One 9: e88242. doi: 10.1371/journal.pone.0088242
![]() |
[54] |
Jagomägi T, Nikopensius T, Krjutškov K, et al. (2010) MTHFR and MSX1 contribute to the risk of nonsyndromic cleft lip/palate. Eur J Oral Sci 118: 213-220. doi: 10.1111/j.1600-0722.2010.00729.x
![]() |
[55] |
Borkar AS (1993) Epidemiology of facial clefts in the central province of Saudi Arabia. Br J Plast Surg 46: 673-675. doi: 10.1016/0007-1226(93)90198-K
![]() |
[56] | Burdick AB (1986) Genetic epidemiology and control of genetic expression in Van der Woude syndrome. J Craniofac Genet Dev Biol Suppl 2: 99-105. |
[57] |
Kondo S, Schutte BC, Richardson RJ, et al. (2002) Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet 32: 285-289. doi: 10.1038/ng985
![]() |
[58] |
Zucchero TM, Cooper ME, Maher BS, et al. (2004) Interferon regulatory factor 6 (IRF6) gene variantsand the risk of isolated cleft lip or palate. N Engl J Med 351: 769-780. doi: 10.1056/NEJMoa032909
![]() |
[59] |
Blanton SH, Cortez A, Stal S, et al. (2005) Variation in IRF6 contributes to nonsyndromic cleft lip and palate. Am J Med Genet A 137: 259-262. doi: 10.1002/ajmg.a.30887
![]() |
[60] |
Jugessur A, Rahimov F, Lie RT, et al. (2008) Genetic variants in IRF6 and the risk of facial clefts: single-marker and haplotype-based analyses in a population-based case-control study of facial clefts in Norway. Genet Epidemiol 32: 413-424. doi: 10.1002/gepi.20314
![]() |
[61] |
Huang Y, Wu J, Ma J, et al. (2009) Association between IRF6 SNPs and oral clefts in West China. J Dent Res 88: 715-718. doi: 10.1177/0022034509341040
![]() |
[62] |
Grant SF, Wang K, Zhang H, et al. (2009) A Genome-Wide Association Study Identifies a Locus for Nonsyndromic Cleft Lip with or without Cleft Palate on 8q24. J Pediatr 155: 909-913. doi: 10.1016/j.jpeds.2009.06.020
![]() |
[63] |
Beaty TH, Murray JC, Marazita ML, et al. (2010) A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4. Nat Genet 42: 525-529. doi: 10.1038/ng.580
![]() |
[64] |
Ibarra-Arce A, García-Álvarez M, Cortés-González D (2015) IRF6 polymorphisms in Mexican patients with non-syndromic cleft lip. Meta Gene 4: 8-16. doi: 10.1016/j.mgene.2015.02.002
![]() |
[65] |
Satokata I, Maas R (1994) Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat Genet 6: 348-356. doi: 10.1038/ng0494-348
![]() |
[66] |
Van den Boogaard MJ, Dorland M, Beemer FA, et al. (2000) MSX1 mutation is associated with Orofacial clefting and tooth agenesis in humans. Nat Genet 24: 342-343. doi: 10.1038/74155
![]() |
[67] |
Jezewski PA, Vieira AR, Nishimura C, et al. (2003) Complete sequencing shows a role for MSX1 in nonsyndromic cleft lip and palate. J Med Genet 40: 399-407. doi: 10.1136/jmg.40.6.399
![]() |
[68] |
Otero L, Gutierrez S, Chaves M, et al. (2007) Association of MSX1 with nonsyndromic cleft lip and palate in a Colombian population. Cleft palate craniofac J 44: 653-656. doi: 10.1597/06-097.1
![]() |
[69] |
Salahshourifar I, Halim AS, Sulaiman WA, et al. (2011) Contribution of MSX1 variants to the risk of non-syndromic cleft lip and palate in a Malay population. J Hum Genet 56: 755-758. doi: 10.1038/jhg.2011.95
![]() |
[70] | Indencleef K, Roosenboom J, Hoskens H, et al. (2018) Six NSCL/P loci show associations with normal-range craniofacial variation. Front. Genet 9: 502. |
[71] |
Tasanarong P, Pabalan N, Tharabenjasin P, et al. (2019) MSX1 gene polymorphisms and non-syndromic cleft lip with or without palate (NSCL/P): A meta-analysis. Oral Dis 25: 1492-1501. doi: 10.1111/odi.13127
![]() |
[72] |
Mitchell LE (1997) Transforming growth factor alpha locus and nonsyndromic cleft lip with or without cleft palate: a reappraisal. Genet Epidemiol 14: 231-240. doi: 10.1002/(SICI)1098-2272(1997)14:3<231::AID-GEPI2>3.0.CO;2-8
![]() |
[73] |
Shaw GM, Wasserman CR, Murray JC, et al. (1998) Infant TGF-alpha genotype, orofacial clefts, and maternal periconceptional multivitamin use. Cleft Palate Craniofac J 35: 366-367. doi: 10.1597/1545-1569_1998_035_0366_itagoc_2.3.co_2
![]() |
[74] |
Holder SE, Vintiner GM, Farren B, et al. (1999) Confirmation of an association between RFLPs at the transforming growth factor-alpha locus and nonsyndromic cleft lip and palate. J Med Genet 29: 390-392. doi: 10.1136/jmg.29.6.390
![]() |
[75] |
Passos-Bueno MR, Gaspar DA, Kamiya T, et al. (2004) Transforming growth factor-alpha and non-syndromic cleft lip with or without palate in Brazilian patients: results of large case-control study. Cleft Palate Craniofac J 41: 387-391. doi: 10.1597/03-054.1
![]() |
[76] |
Letra A, Fakhouri W, Renata F, et al. (2012) Interaction between IRF6 and TGFA Genes Contribute to the Risk of Nonsyndromic Cleft Lip/Palate. PLoS One 7: e45441. doi: 10.1371/journal.pone.0045441
![]() |
[77] | Feng C, Zhang E, Duan W, et al. (2014) Association Between Polymorphism of TGFA Taq I and Cleft Lip and/or Palate: A Meta-Analysis. BMC Oral Health 11: 14-88. |
[78] |
Yan C, He DQ, Chen LY, et al. (2018) Transforming Growth Factor Alpha Taq I Polymorphisms and Nonsyndromic Cleft Lip and/or Palate Risk: A Meta-Analysis. Cleft Palate Craniofac J 55: 814-820. doi: 10.1597/16-008
![]() |
[79] |
Suzuki S, Marazita ML, Cooper ME, et al. (2009) Mutations in BMP4 are associated with subepithelial, microform, and overt cleft lip. Am J Hum Genet 84: 406-411. doi: 10.1016/j.ajhg.2009.02.002
![]() |
[80] |
Antunes LS, Küchler EC, Tannure PN, et al. (2013) BMP4 Polymorphism is Associated with Nonsyndromic Oral Cleft in a Brazilian Population. Cleft Palate Craniofac J 50: 633-638. doi: 10.1597/12-048
![]() |
[81] |
Li YH, Yang J, Zhang JL, et al. (2017) BMP4 rs17563 polymorphism and nonsyndromic cleft lip with or without cleft palate: a meta- analysis. Medicine (Baltim) 96: e7676. doi: 10.1097/MD.0000000000007676
![]() |
[82] |
Hao J, Gao R, Wua W, et al. (2018) Association between BMP4 gene polymorphisms and cleft lip with or without cleft palate in a population from South China. Arch Oral Biol 93: 95-99. doi: 10.1016/j.archoralbio.2018.05.015
![]() |
[83] |
Assis Machado R, De Toledo IP, Martelli-Junior H, et al. (2018) Potential genetic markers for nonsyndromic oral clefts in the Brazilian population: a systematic review and meta-analysis. Birth Defects Res 110: 827-839. doi: 10.1002/bdr2.1208
![]() |
[84] | Mansouri A, Stoykova A, Torres M, et al. (1996) Dysgenesis of cephalic neural crest derivatives in Pax7 mutant mice. Development 122: 831-838. |
[85] |
Sull JW, Liang KY, Hetmanski JB, et al. (2009) Maternal transmission effects of the PAX genes among cleft case-parent trios from four populations. Eur J Hum Genet 17: 831-839. doi: 10.1038/ejhg.2008.250
![]() |
[86] |
Ludwig KU, Mangold E, Herms S, et al. (2012) Genome-wide meta-analyses of non syndromic cleft lip with or without cleft palate identify six new risk loci. Nat Genet 44: 968-971. doi: 10.1038/ng.2360
![]() |
[87] |
Beaty TH, Taub MA, Scott AF, et al. (2013) confirming genes influencing risk to Cleft lip with or without cleft palate in a case – parent trio study. Hum Genet 132: 771-781. doi: 10.1007/s00439-013-1283-6
![]() |
[88] |
Leslie EJ, Taub MA, Liu H, et al. (2015) Identification of Functional Variants for Cleft Lip with or without Cleft Palate in or near PAX7, FGFR2 and NOG by Targeted Sequencing of GWAS Loci. Am J Hum Genet 96: 397-411. doi: 10.1016/j.ajhg.2015.01.004
![]() |
[89] | Duan SJ, Huang N, Zhang BH, et al. (2017) New insights from GWAS for the cleft palate among han Chinese population. Med Oral Patol Oral Cir Bucal 22: e219-e227. |
[90] |
Gaczkowska A, Biedziak B, Budner M, et al. (2019) PAX7 nucleotide variants and the risk of non-syndromicorofacial clefts in the Polish population. Oral Dis 25: 1608-1618. doi: 10.1111/odi.13139
![]() |
[91] |
Otto F, Kanegane H, Mundlos S (2002) Mutations in the RUNX2 gene in patients with cleidocranial dysplasia. Hum Mutat 19: 209-216. doi: 10.1002/humu.10043
![]() |
[92] |
Cooper SC, Flaitz CM, Johnston DA, et al. (2001) A natural history of cleidocranial dysplasia. Am J Med Genet 104: 1-6. doi: 10.1002/ajmg.10024
![]() |
[93] |
Aberg T, Cavender A, Gaikwad JS, et al. (2004) Phenotypic changes in dentition of Runx2 homozygote-null mutant mice. J Histochem Cytochem 52: 131. doi: 10.1177/002215540405200113
![]() |
[94] |
Sull JW, Liang KY, Hetmanski JB, et al. (2008) Differential parental transmission of markers in RUNX2 among cleft case-parent trios from four populations. Genet Epidemiol 32: 505-512. doi: 10.1002/gepi.20323
![]() |
[95] |
Wu T, Daniele M, Fallin MD, et al. (2012) Evidence of Gene-Environment Interaction for the RUNX2 Gene and Environmental Tobacco Smoke in Controlling the Risk of Cleft Lip with/without Cleft Palate. Birth Defects Res A Clin Mol Teratol 94: 76-83. doi: 10.1002/bdra.22885
![]() |
[96] |
Alkuraya FS, Saadi I, Lund JJ, et al. (2006) SUMO1 haploinsufficiency leads to cleft lip and palate. Science 313: 1751. doi: 10.1126/science.1128406
![]() |
[97] |
Song T, Li G, Jing G, et al. (2008) SUMO1 polymorphisms are associated with non-syndromic cleft lip with or without cleft palate. Biochem Biophys Res Commun 377: 1265-1268. doi: 10.1016/j.bbrc.2008.10.138
![]() |
[98] | Carter TC, Molloy AM, Pangilinan F, et al. (2010) Testing reported associations of genetic risk factors for oral clefts in a large Irish study population. Birth Defects Res A Clin Mol Teratol 88: 84-93. |
[99] |
Tang MR, Wang YX, Han SY, et al. (2014) SUMO1 genetic polymorphisms may contribute to the risk of nonsyndromic cleft lip with or without palate: a meta-analysis. Genet Test Mol Biomarkers 18: 616-624. doi: 10.1089/gtmb.2014.0056
![]() |
[100] |
Hallonet M, Hollemann T, Pieler T, et al. (1999) VAX1, a novel homeobox-containing gene, directs development of the basal forebrain and visual system. Genes Dev 13: 3106-3114. doi: 10.1101/gad.13.23.3106
![]() |
[101] |
Slavotinek AM, Chao R, Vacik T, et al. (2012) VAX1 mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: the first description of a VAX1 phenotype in humans. Hum Mutat 33: 364-368. doi: 10.1002/humu.21658
![]() |
[102] |
Butali A, Suzuki S, Cooper ME, et al. (2013) Replication of Genome Wide Association Identified Candidate Genes Confirm the Role of Common and Rare Variants in PAX7 and VAX1 in the Etiology of Non-syndromic CL/P. Am J Med Genet A 161: 965-972. doi: 10.1002/ajmg.a.35749
![]() |
[103] |
Zhang BH, Shi JY, Lin YS, et al. (2018) VAX1 Gene Associated Non-Syndromic Cleft Lip With or Without Palate in Western Han Chinese. Arch Oral Biol 95: 40-43. doi: 10.1016/j.archoralbio.2018.07.014
![]() |
[104] |
Sabbagh HJ, Innes NPT, Ahmed ES, et al. (2019) Molecular Screening of VAX1 Gene Polymorphisms Uncovered the Genetic Heterogeneity of Nonsyndromic Orofacial Cleft Among Saudi Arabian Patients. Genet Test Mol Biomarkers 23: 45-50. doi: 10.1089/gtmb.2018.0207
![]() |
[105] |
De Felice M, Ovitt C, Biffali E, et al. (1998) A mouse model for hereditary thyroid dysgenesis and cleft palate. Nature Genet 19: 395-398. doi: 10.1038/1289
![]() |
[106] |
Bamforth JS, Hughes IA, Lazarus JH, et al. (1989) Congenital hypothyroidism, spiky hair, and cleft palate. J Med Genet 26: 49-60. doi: 10.1136/jmg.26.1.49
![]() |
[107] |
Castanet M, Park SM, Smith A, et al. (2002) A novel loss-of-function mutation in TTF-2 is associated with congenital hypothyroidism, thyroid agenesis and cleft palate. Hum Mol Genet 11: 2051-2059. doi: 10.1093/hmg/11.17.2051
![]() |
[108] |
Nikopensius T, Kempa I, Ambrozaitytė L, et al. (2011) Variation in FGF1, FOXE1, and TIMP2 genes is associated with nonsyndromic cleft lip with or without cleft palate. Birth Defects Re Part A 91: 218-225. doi: 10.1002/bdra.20791
![]() |
[109] |
Leslie EJ, Carlson JC, Shaffer JR, et al. (2017) Genome-wide meta-analyses of nonsyndromicorofacial clefts identify novel associations between FOXE1 and all orofacial clefts, and TP63 and cleft lip with or without cleft palate. Hum Genet 136: 275-286. doi: 10.1007/s00439-016-1754-7
![]() |
[110] |
Chiquet BT, Lidral AC, Stal S, et al. (2007) CRISPLD2: a novel NSCLP candidate gene. Hum Mol Genet 16: 2241-2248. doi: 10.1093/hmg/ddm176
![]() |
[111] |
Shi J, Jiao X, Song T, et al. (2010) CRISPLD2 polymorphisms are associated with nonsyndromic cleft lip with or without cleft palate in a northern Chinese population. Eur J Oral Sci 118: 430-433. doi: 10.1111/j.1600-0722.2010.00743.x
![]() |
[112] |
Letra A, Menezes R, Margaret E, et al. (2011) CRISPLD2 Variants Including a C471T Silent Mutation May Contribute to Nonsyndromic Cleft Lip with or without Cleft Palate. Cleft Palate Craniofac J 48: 363-370. doi: 10.1597/09-227
![]() |
[113] |
Mijiti A, Ling W, Maimaiti A, et al. (2015) Preliminary evidence of an interaction between the CRISPLD2 gene and non-syndromic cleft lip with or without cleft palate (nsCL/P) in Xinjiang Uyghur population, China. Int J Pediatr Otorhinolaryngol 79: 94-100. doi: 10.1016/j.ijporl.2014.10.043
![]() |
[114] |
Chiquet BT, Yuan Q, Swindell EC, et al. (2018) Knockdown of Crispld2 in zebrafish identifies a novel network for nonsyndromic cleft lip with or without cleft palate candidate genes. Eur J Hum Genet 26: 1441-1450. doi: 10.1038/s41431-018-0192-5
![]() |
[115] |
Greene ND, Dunlevy LP, Copp AJ (2003) Homocysteine Is Embryo toxic but Does Not Cause Neural Tube Defects in Mouse Embryos. Anat Embryo 206: 185-191. doi: 10.1007/s00429-002-0284-3
![]() |
[116] |
Gaspar DA, Matioli SR, Pavanello RC, et al. (2004) Maternal MTHFR Interacts With the Offspring's BCL3 Genotypes, but Not With TGFA, in Increasing Risk to Nonsyndromic Cleft Lip With or Without Cleft Palate. Eur J Hum Genet 12: 521-526. doi: 10.1038/sj.ejhg.5201187
![]() |
[117] |
Rai V (2018) Strong Association of C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene With Nosyndromic Cleft Lip/Palate (nsCL/P). Indian J Clin Biochem 33: 5-15. doi: 10.1007/s12291-017-0673-2
![]() |
[118] |
Bhaskar L, Murthy J, Babu GV (2011) Polymorphisms in Genes Involved in Folate Metabolism and Orofacial Clefts. Arch Oral Biol 56: 723-737. doi: 10.1016/j.archoralbio.2011.01.007
![]() |
[119] |
Machado AR, De Toledo IP, Martelli H, et al. (2018) Potential genetic markers for nonsyndromic oral clefts in the Brazilian population: a systematic review and meta-analysis. Birth Defects Res 110: 827-839. doi: 10.1002/bdr2.1208
![]() |
[120] |
Lin L, Bu H, Yang Y, et al. (2017) A Targeted, Next-Generation Genetic Sequencing Study on Tetralogy of Fallot, Combined With Cleft Lip and Palate. J Craniofac Surg 28: e351-e355. doi: 10.1097/SCS.0000000000003598
![]() |
[121] |
Lan Y, Ryan RC, Zhang Z, et al. (2006) Expression of Wnt9b and activation of canonical Wnt signaling during midfacial morphogenesis in mice. Dev Dyn 235: 1448-1454. doi: 10.1002/dvdy.20723
![]() |
[122] |
Carroll TJ, Park JS, Hayashi S, et al. (2005) Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell 9: 283-292. doi: 10.1016/j.devcel.2005.05.016
![]() |
[123] |
Karner CM, Chirumamilla R, Aoki S, et al. (2009) Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis. Nature Genet 41: 793-799. doi: 10.1038/ng.400
![]() |
[124] |
Juriloff DM, Harris MJ, McMahon AP, et al. (2006) Wnt9b is the mutated gene involved in multifactorial nonsyndromic cleft lip with or without cleft palate in A/WySn mice, as confirmed by a genetic complementation test. Birth Defects Res A Clin Mol Teratol 76: 574-579. doi: 10.1002/bdra.20302
![]() |
[125] |
Chiquet BT, Blanton SH, Burt A, et al. (2008) Variation in WNT genes is associated with non-syndromic cleft lip with or without cleft palate. Hum Mol Genet 17: 2212-2218. doi: 10.1093/hmg/ddn121
![]() |
[126] |
Menezes R, Letra A, Kim AH, et al. (2010) Studies with Wnt genes and nonsyndromic cleft lip and palate. Birth Defects Res A Clin Mol Teratol 88: 995-1000. doi: 10.1002/bdra.20720
![]() |
[127] |
Fontoura C, Silva RM, Granjeiro JM, et al. (2015) Association of WNT9B Gene Polymorphisms With Nonsyndromic Cleft Lip With or Without Cleft Palate in Brazilian Nuclear Families. Cleft Palate Craniofac J 52: 44-48. doi: 10.1597/13-146
![]() |
[128] |
Vijayan V, Ummer R, Weber R, et al. (2018) Association of WNT Pathway Genes With Nonsyndromic Cleft Lip With or Without Cleft Palate. Cleft Palate Craniofac J 55: 335-341. doi: 10.1177/1055665617732782
![]() |
[129] |
Marini NJ, Asrani K, Yang W, et al. (2019) Accumulation of rare coding variants in genes implicated in risk of human cleft lip with or without cleft palate. Am J Med Genet 179: 1260-1269. doi: 10.1002/ajmg.a.61183
![]() |
[130] |
Gajera M, Desai N, Suzuki A, et al. (2019) MicroRNA-655-3p and microRNA-497-5p inhibit cell proliferation in cultured human lip cells through the regulation of genes related to human cleft lip. BMC Med Genomics 12: 70. doi: 10.1186/s12920-019-0535-2
![]() |
[131] |
Kim SJ, Lee S, Park HJ, et al. (2016) Genetic association of MYH genes with hereditary hearing loss in Korea. Gene 591: 177-182. doi: 10.1016/j.gene.2016.07.011
![]() |
[132] |
Pazik J, Lewandowski Z, Oldak M, et al. (2016) Association of MYH9 rs3752462 and rs5756168 polymorphisms with transplanted kidney artery stenosis. Transplant Proc 48: 1561-1565. doi: 10.1016/j.transproceed.2016.01.085
![]() |
[133] |
Marigo V, Nigro A, Pecci A, et al. (2004) Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains. Genomics 83: 1125-1133. doi: 10.1016/j.ygeno.2003.12.012
![]() |
[134] |
Martinelli M, Di Stazio M, Scapoli L, et al. (2007) Cleft lip with or without cleft palate: implication of the heavy chain of non-muscle myosin IIA. J Med Genet 44: 387-392. doi: 10.1136/jmg.2006.047837
![]() |
[135] |
Chiquet BT, Hashmi SS, Henry R, et al. (2009) Genomic screening identifies novel linkages and provides further evidence for a role of MYH9 in nonsyndromic cleft lip and palate. Eur J Hum Genet 17: 195-204. doi: 10.1038/ejhg.2008.149
![]() |
[136] |
Jia ZL, Li Y, Chen CH, et al. (2010) Association among polymorphisms at MYH9, environmental factors, and nonsyndromicorofacial clefts in western China. DNA Cell Biol 29: 25-32. doi: 10.1089/dna.2009.0935
![]() |
[137] |
Peng HH, Chang NC, Chen KT, et al. (2016) Nonsynonymous variants in MYH9 and ABCA4 are the most frequent risk loci associated with nonsyndromicorofacial cleft in Taiwanese population. BMC Med Genet 17: 59. doi: 10.1186/s12881-016-0322-2
![]() |
[138] |
Wang Y, Li D, Xu Y, et al. (2018) Functional Effects of SNPs in MYH9 and Risks of Nonsyndromic Orofacial Clefts. J Dent Res 97: 388-394. doi: 10.1177/0022034517743930
![]() |
[139] |
Araujo TK, Secolin R, Félix TM, et al. (2016) A multicentric association study between 39 genes and nonsyndromic cleft lip and palate in a Brazilian population. J Craniomaxillofac Surg 44: 16-20. doi: 10.1016/j.jcms.2015.07.026
![]() |
[140] |
Yu Y, Zuo X, He M, et al. (2017) Genome-wide analyses of non-syndromic cleft lip with palate identify 14 novel loci and genetic heterogeneity. Nat Commun 8: 14364. doi: 10.1038/ncomms14364
![]() |
[141] |
Da Silva HPV, Oliveira GHM, Ururahy MAG, et al. (2018) Application of high-resolution array platform for genome-wide copy number variation analysis in patients with nonsyndromic cleft lip and palate. J Clin Lab Anal 32: e22428. doi: 10.1002/jcla.22428
![]() |
[142] |
Huang L, Jia Z, Shi Y, et al. (2019) Genetic factors define CPO and CLO subtypes of nonsyndromicorofacial cleft. PLoS Genet 15: e1008357. doi: 10.1371/journal.pgen.1008357
![]() |
[143] | Gorlin RJ, Cohen MM, Hennekam RCM (2001) Syndromes of the Head and Neck New York: Oxford University Press. |
[144] |
Grosen D, Chevrier C, Skytthe A, et al. (2010) A cohort study of recurrence patterns among more than 54000 relatives of oral cleft cases in Denmark: support for the multifactorial threshold model of inheritance. J Med Genet 47: 162-168. doi: 10.1136/jmg.2009.069385
![]() |
[145] |
Lidral AC, Romitti PA, Basart AM, et al. (1998) Association of MSX1 and TGFB3 with nonsyndromicclefting in humans. Am J Hum Genet 63: 557-568. doi: 10.1086/301956
![]() |
[146] |
Suazo J, Santos JL, Scapoli L, et al. (2010) Association between TGFB3 and nonsyndromic cleft lip with or without cleft palate in a Chilean population. Cleft Palate Craniofac J 47: 513-517. doi: 10.1597/09-015
![]() |
[147] |
Vieira AR, Avila JR, Daack-Hirsch S, et al. (2005) Medical sequencing of candidate genes for nonsyndromic cleft lip and palate. PLoS Genet 1: e64. doi: 10.1371/journal.pgen.0010064
![]() |
[148] |
Choi SJ, Marazita ML, Hart PS, et al. (2009) The PDGF-C regulatory region SNP rs28999109 decreases promoter transcriptional activity and is associated with CL/P. Eur J Hum Genet 17: 774-784. doi: 10.1038/ejhg.2008.245
![]() |
[149] |
François-Fiquet C, Poli-Merol ML, Nguyen P, et al. (2014) Role of angiogenesis-related genes in cleft lip/palate: review of the literature. Int J Pediatr Otorhinolaryngol 78: 1579-1585. doi: 10.1016/j.ijporl.2014.08.001
![]() |
[150] |
Carlson JC, Taub MA, Feingold E, et al. (2017) Identifying Genetic Sources of Phenotypic Heterogeneity in Orofacial Clefts by Targeted Sequencing. Birth Defects Res 109: 1030-1038. doi: 10.1002/bdr2.23605
![]() |
[151] |
Figueiredo JC, Stephanie LY, Raimondi H, et al. (2014) Genetic risk factors for orofacial clefts in Central Africans and Southeast Asians. Am J Med Genet A 164A: 2572-2580. doi: 10.1002/ajmg.a.36693
![]() |
[152] |
Leslie EJ, Taub MA, Liu H, et al. (2015) Identification of Functional Variants for Cleft Lip with or without Cleft Palate in or near PAX7, FGFR2, and NOG by Targeted Sequencing of GWAS Loci. Am J Hum Genet 96: 397-411. doi: 10.1016/j.ajhg.2015.01.004
![]() |
[153] |
Moreno Uribe LM, Fomina T, Munger RG, et al. (2017) A Population-Based Study of Effects of Genetic Loci on Orofacial Clefts. J Dent Res 96: 1322-1329. doi: 10.1177/0022034517716914
![]() |
[154] |
Liu H, Leslie EJ, Carlson JC, et al. (2017) Identification of common non-coding variants at 1p22 that are functional for non-syndromic orofacial clefting. Nat Commun 8: 14759. doi: 10.1038/ncomms14759
![]() |
[155] |
Cox LL, Cox TC, Moreno Uribe LM, et al. (2018) Mutations in the Epithelial Cadherin-p120-Catenin Complex Cause Mendelian Non-Syndromic Cleft Lip with or without Cleft Palate. Am J Hum Genet 102: 1143-1157. doi: 10.1016/j.ajhg.2018.04.009
![]() |
[156] |
Du S, Yang Y, Yi P, et al. (2019) A Novel CDH1 Mutation Causing Reduced E-Cadherin Dimerization Is Associated with Nonsyndromic Cleft Lip With or Without Cleft Palate. Genet Test Mol Biomarkers 23: 759-765. doi: 10.1089/gtmb.2019.0092
![]() |
[157] |
Beaty TH, Taub MA, Scott AF, et al. (2013) Confirming genes influencing risk to cleft lip with/without cleft palate in a case-parent trio study. Hum Genet 132: 771-781. doi: 10.1007/s00439-013-1283-6
![]() |
[158] |
Moreno Uribe LM, Fomina T, Munger RG, et al. (2017) A Population-Based Study of Effects of Genetic Loci on Orofacial Clefts. J Dent Res 96: 1322-1329. doi: 10.1177/0022034517716914
![]() |
[159] |
Ghazali N, Rahman NA, Kannan TP, et al. (2015) Screening of Transforming Growth Factor Beta 3 and Jagged2 Genes in the Malay Population With Nonsyndromic Cleft Lip With or Without Cleft Palate. Cleft Palate Craniofac J 52: e88-94. doi: 10.1597/14-024
![]() |
[160] |
Simioni M, Araujo TK, Monlleo IL, et al. (2014) Investigation of genetic factors underlying typical orofacial clefts: mutational screening and copy number variation. J Hum Genet 60: 17-25. doi: 10.1038/jhg.2014.96
![]() |
[161] |
Shi M, Christensen K, Weinberg CR, et al. (2007) Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants. Am J Hum Genet 80: 76-90. doi: 10.1086/510518
![]() |
[162] |
Song T, Wu D, Wang Y, et al. (2013) Association of NAT1 and NAT2 genes with nonsyndromic cleft lip and palate. Mol Med Rep 8: 211-216. doi: 10.3892/mmr.2013.1467
![]() |
[163] |
Sull JW, Liang KY, Hetmanski JB, et al. (2009) Maternal transmission effects of the PAX genes among cleft case-parent trios from four populations. Eur J Hum Genet 17: 831-839. doi: 10.1038/ejhg.2008.250
![]() |
[164] |
Laumonnier F, Holbert S, Ronce N, et al. (2005) Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate. J Med Genet 42: 780-786. doi: 10.1136/jmg.2004.029439
![]() |
[165] |
Loenarz C, Ge W, Coleman ML, et al. (2010) PHF8, a gene associated with cleft lip/palate and mental retardation, encodes for an Nepsilon-dimethyl lysine demethylase. Hum Mol Genet 19: 217-222. doi: 10.1093/hmg/ddp480
![]() |
[166] |
Peanchitlertkajorn S, Cooper ME, Liu YE, et al. (2003) Chromosome 17: gene mapping studies of cleft lip with or without cleft palate in Chinese families. Cleft Palate Craniofac J 40: 71-79. doi: 10.1597/1545-1569_2003_040_0071_cgmsoc_2.0.co_2
![]() |
[167] |
Letra A, Silva RA, Menezes R, et al. (2007) MMP gene polymorphisms as contributors for cleft lip/palate: association with MMP3 but not MMP1. Arch Oral Biol 52: 954-960. doi: 10.1016/j.archoralbio.2007.04.005
![]() |
[168] |
Kumari P, Singh SK, Raman R (2019) TGFβ3, MSX1, and MMP3 as Candidates for NSCL±P in an Indian Population. Cleft Palate Craniofac J 56: 363-372. doi: 10.1177/1055665618775727
![]() |
[169] |
Letra A, Silva RM, Motta LG, et al. (2012) Association of MMP3 and TIMP2 promoter polymorphisms with nonsyndromic oral clefts. Birth Defects Res A Clin Mol Teratol 94: 540-548. doi: 10.1002/bdra.23026
![]() |
[170] |
Letra A, Zhao M, Silva RM, et al. (2014) Functional Significance of MMP3 and TIMP2 Polymorphisms in Cleft Lip/Palate. J Dent Res 93: 651-656. doi: 10.1177/0022034514534444
![]() |
1. | Noor U Huda, Hazik B Shahzad, Maria Noor, Yaser Ishaq, Malik Adeel Anwar, Muhammad Kashif, Frequency of Different Dental Irregularities Associated With Cleft Lip and Palate in a Tertiary Care Dental Hospital, 2021, 2168-8184, 10.7759/cureus.14456 | |
2. | Agung Sosiawan, Mala Kurniati, Coen Pramono Danudiningrat, Dian Agustin Wahjuningrum, Indra Mulyawan, The role of family history as a risk factor for non-syndromic cleft lip and/or palate with multifactorial inheritance, 2021, 54, 2442-9740, 108, 10.20473/j.djmkg.v54.i2.p108-112 | |
3. | Mahamad Irfanulla Khan, Prashanth CS, Narasimhamurty Srinath, Role of PAX7 Gene rs766325 and rs4920520 Polymorphisms in the Etiology of Non-syndromic Cleft Lip and Palate: A Genetic Study, 2022, 09, 2699-9404, 208, 10.1055/s-0042-1748531 | |
4. | Babak Choobi Anzali, Nasim Talebiazar, Rasoul Goli, Mansour Arad, Samira Norouzrajabi, Sheida Muhammadi, Behnam Babamiri, Cerebro-oculo-nasal syndrome, a congenital anomaly: A rare case report, 2022, 47, 24058572, 100539, 10.1016/j.ijso.2022.100539 | |
5. | Mona Habibi, Shaghayegh Vahdat, Evaluation of the Correlation between Socioeconomic Factors and Pediatric Cleft Lip and Palate, 2021, 4, 2371-770X, 40, 10.30699/mmlj17.4.2.40 | |
6. | Mahamad Irfanulla Khan, Prashanth CS, N. Srinath, Praveen K. Neela, Mohammed K. Mohiuddin, Genetic Analysis of the Single-Nucleotide Polymorphisms rs880810, rs545793, rs80094639, and rs13251901 in Nonsyndromic Oral Clefts: A Case–Parent Trio Study, 2023, 10, 2699-9404, 034, 10.1055/s-0043-1764399 | |
7. | Kinga Amália Sándor-Bajusz, Teodor Barna Maros, Lajos Olasz, George Kálmán Sándor, Kinga Hadzsiev, Attila Mihály Vástyán, The Influence of Genetic Syndromes on the Algorithm of Cleft Lip and Palate Repair – A Retrospective Study, 2021, 11, 2231-0746, 270, 10.4103/ams.ams_77_21 | |
8. | Martin Zibrín, Marianna Zábavníková, Lenka Baňacká, Katarína Holovská, Peter Kizek, Tatiana Komorová, Andrej Jenča, Structure of Soft Tissues in Congenital Unilateral Cleft Lip, Light and Electron Microscopic Observations, 2024, 68, 2453-7837, 62, 10.2478/fv-2024-0008 | |
9. | Maryam Rahnama, Tahereh Movahedi, Atieh Eslahi, Nasrin Kaseb-Mojaver, Masoome Alerasool, Nasim Adabi, Majid Mojarrad, Identification of a novel mutation of Platelet-Derived Growth Factor-C (PDGFC) gene in a girl with Non-Syndromic cleft lip and palate, 2024, 910, 03781119, 148335, 10.1016/j.gene.2024.148335 | |
10. | Arwa Babai, Melita Irving, Orofacial Clefts: Genetics of Cleft Lip and Palate, 2023, 14, 2073-4425, 1603, 10.3390/genes14081603 | |
11. | Arun Meyyazhagan, Haripriya Kuchi Bhotla, Manikantan Pappuswamy, Valentina Tsibizova, Karthick Kumar Alagamuthu, Gian Carlo Di Renzo, 2023, Chapter 4, 978-3-031-31757-6, 57, 10.1007/978-3-031-31758-3_4 | |
12. | Nada Abdelhafez, Amani Aladsani, Lateefa Alkharafi, Suzanne Al-Bustan, Association of selected gene variants with nonsyndromic orofacial clefts in Kuwait, 2025, 934, 03781119, 149028, 10.1016/j.gene.2024.149028 | |
13. | Martin Kamau, Krishan Sarna, Symon Guthua, Khushboo Jayant Sonigra, Paul Kimani, Patterns of primary and secondary defects associated with non‐syndromic cleft lip and palate: An epidemiological analysis in a Kenyan population, 2024, 64, 0914-3505, 134, 10.1111/cga.12564 |
Gene | Chromosomal location | OMIM | Evidence | References |
IRF6 | 1q32.2 | 607199 | GWAS, LD, L, M | [57],[60],[62],[64] |
MSX1 | 4p16.2 | 142983 | LD, M, GWAS | [65],[67],[69]–[71] |
TGFA | 2p13.3 | 190170 | LD, GWAS | [73],[75],[76],[78] |
BMP4 | 14q22.2 | 112262 | M | [79],[81],[83] |
PAX7 | 1p36.13 | 167410 | GWAS | [85],[87],[89],[90] |
RUNX2 | 6p21.1 | 600211 | GWAS | [91],[93],[95] |
SUMO1 | 2q33.1 | 601912 | M | [96],[98],[99] |
VAX1 | 10q25.3 | 604294 | GWAS, LD | [100],[102],[104] |
FOXE1 | 9q22.33 | 602617 | L, LD, M | [108],[109] |
CRISPLD2 | 16q24.1 | 612434 | LD, GWAS | [110],[112],[113] |
MTHFR | 1p36.22 | 607093 | LD, GWAS | [116],[118] |
WNT9B | 17q21.32 | 602864 | M, LD | [122],[124],[127] |
MYH9 | 22q12.3 | 160775 | LD | [134],[136],[138] |
TGFB3 | 14q24.3 | 190230 | M, LD,GWAS | [145],[146] |
SPRY2 | 13q31.1 | 602466 | M | [147],[157] |
PDGFC | 4q32.1 | 608452 | LD, M | [148],[149] |
FGFR2 | 10q26.13 | 176943 | M | [150] |
NOG | 17q22 | 602991 | GWAS, LD | [151],[152] |
ARHGAP29 | 1p22.1 | 610496 | M, GWAS | [153],[154],[157] |
CDH1 | 16q22.1 | 192090 | M | [155],[156] |
THADA | 2p21 | 611800 | GWAS | [157],[158] |
GSTM1 | 1p13.3 | 138350 | M | [45] |
JAG2 | 14q32.33 | 602570 | M, LD | [147],[159] |
KIF7 | 15q26.1 | 611254 | M | [139],[160] |
NAT2 | 8p22 | 612182 | LD | [161],[162] |
PAX3 | 2q36.1 | 606597 | GWAS | [163] |
PHF8 | Xp11.22 | 300560 | M | [164],[165] |
RARA | 17q21.2 | 180240 | L | [166] |
MMP3 | 11q22.2 | 185250 | M | [167],[168] |
TIMP2 | 17q25.3 | 188825 | M, LD | [169],[170] |
Notes: *GWAS: Genome-wide association studies, L: Linkage, M: Mutations, LD: Linkage disequilibrium.
Gene | Chromosomal location | OMIM | Evidence | References |
IRF6 | 1q32.2 | 607199 | GWAS, LD, L, M | [57],[60],[62],[64] |
MSX1 | 4p16.2 | 142983 | LD, M, GWAS | [65],[67],[69]–[71] |
TGFA | 2p13.3 | 190170 | LD, GWAS | [73],[75],[76],[78] |
BMP4 | 14q22.2 | 112262 | M | [79],[81],[83] |
PAX7 | 1p36.13 | 167410 | GWAS | [85],[87],[89],[90] |
RUNX2 | 6p21.1 | 600211 | GWAS | [91],[93],[95] |
SUMO1 | 2q33.1 | 601912 | M | [96],[98],[99] |
VAX1 | 10q25.3 | 604294 | GWAS, LD | [100],[102],[104] |
FOXE1 | 9q22.33 | 602617 | L, LD, M | [108],[109] |
CRISPLD2 | 16q24.1 | 612434 | LD, GWAS | [110],[112],[113] |
MTHFR | 1p36.22 | 607093 | LD, GWAS | [116],[118] |
WNT9B | 17q21.32 | 602864 | M, LD | [122],[124],[127] |
MYH9 | 22q12.3 | 160775 | LD | [134],[136],[138] |
TGFB3 | 14q24.3 | 190230 | M, LD,GWAS | [145],[146] |
SPRY2 | 13q31.1 | 602466 | M | [147],[157] |
PDGFC | 4q32.1 | 608452 | LD, M | [148],[149] |
FGFR2 | 10q26.13 | 176943 | M | [150] |
NOG | 17q22 | 602991 | GWAS, LD | [151],[152] |
ARHGAP29 | 1p22.1 | 610496 | M, GWAS | [153],[154],[157] |
CDH1 | 16q22.1 | 192090 | M | [155],[156] |
THADA | 2p21 | 611800 | GWAS | [157],[158] |
GSTM1 | 1p13.3 | 138350 | M | [45] |
JAG2 | 14q32.33 | 602570 | M, LD | [147],[159] |
KIF7 | 15q26.1 | 611254 | M | [139],[160] |
NAT2 | 8p22 | 612182 | LD | [161],[162] |
PAX3 | 2q36.1 | 606597 | GWAS | [163] |
PHF8 | Xp11.22 | 300560 | M | [164],[165] |
RARA | 17q21.2 | 180240 | L | [166] |
MMP3 | 11q22.2 | 185250 | M | [167],[168] |
TIMP2 | 17q25.3 | 188825 | M, LD | [169],[170] |